Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Tuberculosis

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 232 articles: HTML format

Single Articles

May 2024
1. BURKE RM, Nyirenda SK, Mtenga T, Twabi HH, et al
   Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.
   Clin Infect Dis. 2024 May 15:ciae273. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. SHAH NS, Kityo C, Hughes MD, McCarthy C, et al
   Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
   Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2024
3. SINHA P, Ezhumalai K, Du X, Ponnuraja C, et al
   Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection- a Multicenter Prospective Cohort Analysis.
   Clin Infect Dis. 2024 Apr 23:ciae149. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. FARHAT MR, Jacobson KR
   For Tuberculosis, Not "To Screen or Not to Screen?" but "Who?" and "How?".
   Clin Infect Dis. 2024 Apr 18:ciae058. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. GOSWAMI N, Reed C
   Duration of Effective Tuberculosis Treatment, not Acid-Fast Bacilli (AFB) Smear Status, as the Determinant for Deisolation in Community Settings.
   Clin Infect Dis. 2024 Apr 18:ciae198. doi: 10.1093.
   PubMed    
   
   
   
6. SHAH M, Dansky Z, Nathavitharana R, Behm H, et al
   NTCA Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings.
   Clin Infect Dis. 2024 Apr 18:ciae199. doi: 10.1093.
   PubMed    
   
   
   
7. MARINER-LLICER C, Saavedra Cervera B, Mambuque E, Gomes N, et al
   Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
   Clin Infect Dis. 2024;78:842-845.
   PubMed     Abstract available
   
   
   
8. MIKIASHVILI L, Kempker RR, Chakhaia TS, Bablishvili N, et al
   Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
   Clin Infect Dis. 2024;78:1043-1052.
   PubMed     Abstract available
   
   
   
9. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
   Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
   Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. RODRIGUEZ-MOLINO P, Tebruegge M, Noguera-Julian A, Neth O, et al
    Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.
    Clin Infect Dis. 2024 Apr 3:ciae158. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
11. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
    Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
    Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. MORGAN H, Ndjeka N, Hasan T, Gegia M, et al
    Treatment of multidrug-resistant or rifampicin-resistant tuberculosis with an all-oral 9-month regimen containing linezolid or ethionamide in South Africa: A retrospective cohort study.
    Clin Infect Dis. 2024 Mar 25:ciae145. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. SUNSTRUM J, Power LE, Fligiel HM, Lauter C, et al
    Human Disease due to Mycobacterium bovis Linked to Free-Ranging Deer in Michigan.
    Clin Infect Dis. 2024;78:637-645.
    PubMed     Abstract available
    
    
    
14. KRISHNAN S, Chaisson RE
    US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
    Clin Infect Dis. 2024;78:514-517.
    PubMed     Abstract available
    
    
    
15. NGO HX, Xu AY, Velasquez GE, Zhang N, et al
    Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
    Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
16. CROCKER-BUQUE T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al
    Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
    Clin Infect Dis. 2024 Feb 29:ciad767. doi: 10.1093.
    PubMed    
    
    
    
17. TEIXEIRA LAA, Santos B, Correia MG, Valiquette C, et al
    Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.
    Clin Infect Dis. 2024 Feb 26:ciae101. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. WHITE YN, Solans BP, Denti P, van der Laan LE, et al
    Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis.
    Clin Infect Dis. 2024 Feb 10:ciae024. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. PIVETTA DE ARAUJO RC, Martinez L, da Silva Santos A, Ferreira Lemos E, et al
    Serial Mass Screening for Tuberculosis among Incarcerated Persons in Brazil.
    Clin Infect Dis. 2024 Feb 7:ciae055. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. STEADMAN A, Andama A, Ball A, Mukwatamundu J, et al
    New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics.
    Clin Infect Dis. 2024 Feb 2:ciae041. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
21. MARQUEZ C, Atukunda M, Nugent J, Charlebois ED, et al
    Community-Wide Universal Human Immunodeficiency Virus (HIV) Test and Treat Intervention Reduces Tuberculosis Transmission in Rural Uganda: A Cluster-Randomized Trial.
    Clin Infect Dis. 2024 Jan 16:ciad776. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. KU JH, Fischer H, Qian LX, Li K, et al
    Latent tuberculosis infection testing practices in a large U.S. integrated healthcare system.
    Clin Infect Dis. 2024 Jan 11:ciae015. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. GARCIA LS, Costa AG, Araujo-Pereira M, Spener-Gomes R, et al
    The Xpert(R) MTB/RIF cycle threshold value predicts M. tuberculosis transmission to close contacts in a Brazilian prospective multicenter cohort.
    Clin Infect Dis. 2024 Jan 3:ciad794. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. LINDE L, Brooks MB, Martinez L
    Beyond Diagnosis: Xpert Cycle Threshold Values as Predictors of Tuberculosis Transmission.
    Clin Infect Dis. 2024 Jan 3:ciad791. doi: 10.1093.
    PubMed    
    
    
    December 2023
25. LIN KY, Sun HY, Yang CJ, Lu PL, et al
    Treatment responses to integrase strand-transfer inhibitor-containing antiretroviral regimens in combination with short-course rifapentine-based regimens for latent tuberculosis infection among people with HIV.
    Clin Infect Dis. 2023 Dec 5:ciad730. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2023
26. SCHWALB A, Kayumba K, Houben RMGJ, Bothamley GH, et al
    Recent travel and tuberculosis in migrants: data from a low incidence country.
    Clin Infect Dis. 2023 Nov 6:ciad672. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. LIU X, Xia L, Wang X, Huang Z, et al
    Treatment Outcomes in Multidrug-Resistant Tuberculosis During Pregnancy.
    Clin Infect Dis. 2023 Nov 1:ciad594. doi: 10.1093.
    PubMed    
    
    
    October 2023
28. BROWN TS, Tang L, Omar SV, Joseph L, et al
    Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
    Clin Infect Dis. 2023 Oct 24:ciad596. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. HASAN T, Medcalf E, Nyang'wa BT, Egizi E, et al
    The safety and tolerability of linezolid in novel short-course regimens containing bedaquiline, pretomanid and linezolid to treat rifampicin-resistant tuberculosis: an individual patient data meta-analysis.
    Clin Infect Dis. 2023 Oct 24:ciad653. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. KHAN AR, Tirlangi PK, Wig N, Soneja M, et al
    Immortal Time Bias for Infliximab in Central Nervous System Tuberculosis.
    Clin Infect Dis. 2023 Oct 13:ciad590. doi: 10.1093.
    PubMed    
    
    
    
31. SUNG J, Nantale M, Nalutaaya A, Biche P, et al
    Evidence for tuberculosis in individuals with Xpert Ultra "trace" sputum during screening of high-burden communities.
    Clin Infect Dis. 2023 Oct 3:ciad595. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
32. SAUER SM, Mitnick CD, Khan U, Hewison C, et al
    Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up.
    Clin Infect Dis. 2023 Sep 29:ciad589. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. GUPTA A, Hughes MD, Cruz JL, Avihingsanon A, et al
    Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester.
    Clin Infect Dis. 2023 Sep 28:ciad583. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. KASAIE P, Pennington J, Gupta A, Dowdy DW, et al
    The impact of preventive treatment for multidrug- and rifampin-resistant tuberculosis exceeds trial-based estimates.
    Clin Infect Dis. 2023 Sep 19:ciad557. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. BOAST A, How JA, Lau C, Sett A, et al
    Pre-XDR congenital tuberculosis in an extremely premature baby.
    Clin Infect Dis. 2023 Sep 8:ciad540. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2023
36. BRUMMER LE, Thompson RR, Malhotra A, Shrestha S, et al
    Cost effectiveness of low-complexity screening tests in community-based case-finding for tuberculosis.
    Clin Infect Dis. 2023 Aug 25:ciad501. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. LOTIA FARRUKH I, Lachenal N, Adenov MM, Ahmed S, et al
    Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
    Clin Infect Dis. 2023 Aug 22:ciad445. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. SULIMAN S, Jaganath D, DiNardo A
    Predicting Pediatric Tuberculosis: The Need for Age-Specific Host Biosignatures.
    Clin Infect Dis. 2023;77:450-452.
    PubMed    
    
    
    
39. WALLES J, Winqvist N, Hansson SR, Sturegard E, et al
    Pregnancy outcomes in women screened for tuberculosis infection in Swedish antenatal care.
    Clin Infect Dis. 2023 Aug 12:ciad465. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. BROUGH J, Martinez L, Hatherill M, Zar HJ, et al
    Public health impact and cost-effectiveness of screening for active tuberculosis disease or infection among children in South Africa.
    Clin Infect Dis. 2023 Aug 5:ciad449. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
41. HU Z, Liu K, Zhou M, Jiang X, et al
    Mass tuberculosis screening among the elderly: A population-based study in a well-confined rural county in eastern China.
    Clin Infect Dis. 2023 Jul 28:ciad438. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. WINGFIELD T
    Ending tuberculosis in older people: new strategies for an age-old disease.
    Clin Infect Dis. 2023 Jul 28:ciad439. doi: 10.1093.
    PubMed    
    
    
    
43. ACUNA-VILLAORDUNA C, Fennelly KP, Jones-Lopez EC
    Aerosol Sampling Outperforms Sputum to Predict Mycobacterium tuberculosis Transmission.
    Clin Infect Dis. 2023 Jul 18:ciad372. doi: 10.1093.
    PubMed    
    
    
    
44. S AM, Gautam P, D SSK, Mannam P, et al
    Effectiveness of adjunctive high dose infliximab therapy to improve disability free survival among patients with severe CNS tuberculosis: a matched retrospective cohort study.
    Clin Infect Dis. 2023 Jul 5:ciad401. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
45. MOON SM, Choi H, Kim SH, Kang HK, et al
    Increased lung cancer risk and associated risk factors in tuberculosis survivors: A Korean population-based study.
    Clin Infect Dis. 2023 Jun 22:ciad373. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. LUCZYNSKI P, Holmes T, Romanowski K, Arbiv OA, et al
    Risk of tuberculosis disease in people with chronic kidney disease without kidney failure: A systematic review and meta-analysis.
    Clin Infect Dis. 2023 Jun 13:ciad364. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. IWASE SC, Edlefsen PT, Bhebhe L, Motsumi K, et al
    T-SPOT.TB reactivity in Southern African children with and without in utero HIV exposure.
    Clin Infect Dis. 2023 Jun 9:ciad356. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. SOLANS BP, Imperial MZ, Olugbosi M, Savic RM, et al
    Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial.
    Clin Infect Dis. 2023;76:1903-1910.
    PubMed     Abstract available
    
    
    May 2023
49. ZEEB M, Tepekule B, Kusejko K, Reiber C, et al
    Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland.
    Clin Infect Dis. 2023 May 31:ciad330. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. HALEY CA, Schechter MC, Ashkin D, Peloquin CA, et al
    Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-resistant or rifampin-intolerant TB disease.
    Clin Infect Dis. 2023 May 30:ciad312. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. AHSBERG J, Puplampu P, Kwashie A, Commey JO, et al
    Point-of-care urine LAM testing to guide tuberculosis treatment among severely ill in-patients with HIV in real-world practice: a multi-center stepped wedge cluster-randomized trial from Ghana.
    Clin Infect Dis. 2023 May 26:ciad316. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. KRISHNAN S, Wu X, Kim S, McIntire K, et al
    One-year incidence of tuberculosis infection and disease among household contacts of rifampin- and multi-drug resistant tuberculosis.
    Clin Infect Dis. 2023 May 25:ciad301. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. ROMANOWSKI K, Law MR, Karim ME, Campbell JR, et al
    Healthcare utilization after respiratory tuberculosis: a controlled interrupted time series analysis.
    Clin Infect Dis. 2023 May 9:ciad290. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. BOBAK CA, Botha M, Workman L, Hill JE, et al
    Gene expression in cord blood and tuberculosis in early childhood: A nested case-control study in a South African birth cohort.
    Clin Infect Dis. 2023 May 5:ciad268. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. TIMIRE C, Pedrazzoli D, Boccia D, Houben RM, et al
    Use of a sustainable livelihood framework-based measure to estimate socioeconomic impact of tuberculosis on house-holds.
    Clin Infect Dis. 2023 May 3:ciad273. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. LOUIE JK, Keh C
    Latent Tuberculosis Infection Treatment: Still a Long Road Ahead.
    Clin Infect Dis. 2023 May 1:ciad251. doi: 10.1093.
    PubMed    
    
    
    
57. MELNYCHUK L, Perlman-Arrow S, Bastos M, Menzies D, et al
    A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events.
    Clin Infect Dis. 2023 May 1:ciad246. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2023
58. BURKE RM, Nliwasa M, Dodd PJ, Feasey HR, et al
    Impact of community-wide tuberculosis active case finding and HIV testing on tuberculosis trends in Malawi.
    Clin Infect Dis. 2023 Apr 26:ciad238. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. CHAISSON LH
    Finding tuberculosis: More evidence for community-wide systematic screening.
    Clin Infect Dis. 2023 Apr 26:ciad232. doi: 10.1093.
    PubMed    
    
    
    
60. HUSSAIN H, Jaswal M, Farooq S, Safdar N, et al
    Scale up of rifapentine-isoniazid (3HP) for tuberculosis prevention amongst household contacts in two urban centers: An effectiveness assessment.
    Clin Infect Dis. 2023 Apr 21:ciad245. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. SABET N, Omar T, Milovanovic M, Magajane T, et al
    Undiagnosed pulmonary TB and COVID in adults dying at home in a high TB burden setting, before and during pandemic COVID-19: an autopsy study.
    Clin Infect Dis. 2023 Apr 12:ciad212. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2023
62. UPTON CM, Wiesner L, Dooley KE, Maartens G, et al
    Cerebrospinal Fluid and Tuberculosis Meningitis.
    Clin Infect Dis. 2023 Mar 29:ciad186. doi: 10.1093.
    PubMed    
    
    
    
63. ALLARD-GRAY A, Boakye I, Camara A, Eisenbeis L, et al
    Factors Associated with Discontinuation of Tuberculosis Preventive Treatment: Post-Hoc Analysis of Two Randomized Controlled Trials.
    Clin Infect Dis. 2023 Mar 23:ciad164. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. BONNET M, Gabillard D, Domoua S, Muzoora C, et al
    High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF(R) for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.
    Clin Infect Dis. 2023 Mar 8:ciad125. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. LIU Q, You N, Wen J, Wang J, et al
    Yield and efficiency of a population-based mass tuberculosis screening intervention among persons with diabetes in Jiangsu Province, China.
    Clin Infect Dis. 2023 Mar 3:ciad118. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2023
66. SADOWSKI C, Belknap R, Holland DP, Moro RN, et al
    Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
    Clin Infect Dis. 2023 Feb 23:ciad083. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. PUMA D, Yuen CM, Millones AK, Brooks MB, et al
    Sensitivity of Various Case Detection Algorithms for Community-based Tuberculosis Screening.
    Clin Infect Dis. 2023;76:e987-e989.
    PubMed     Abstract available
    
    
    
68. NTINGINYA NE, Bakuli A, Mapamba D, Sabiiti W, et al
    Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse.
    Clin Infect Dis. 2023;76:e990-e994.
    PubMed     Abstract available
    
    
    
69. EIMER J, Frechet-Jachym M, Le Du D, Caumes E, et al
    Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment.
    Clin Infect Dis. 2023;76:e947-e956.
    PubMed     Abstract available
    
    
    January 2023
70. ORTIZ-BRIZUELA E, Apriani L, Mukherjee T, Lachapelle-Chisholm S, et al
    Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
    Clin Infect Dis. 2023 Jan 23:ciad030. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. LI R, Deutsch-Feldman M, Adams T, Law M, et al
    Transmission of Mycobacterium tuberculosis to healthcare personnel resulting from contaminated bone graft material, United States, June 2021- August 2022.
    Clin Infect Dis. 2023 Jan 20:ciad029. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. NGUYEN HV, Tiemersma E, Nguyen NV, Nguyen HB, et al
    Disease transmission by subclinical tuberculosis patients.
    Clin Infect Dis. 2023 Jan 20:ciad027. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. 
    Correction to: Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis.
    Clin Infect Dis. 2023;76:374.
    PubMed    
    
    
    
74. BERHANU RH, Lebina L, Nonyane BAS, Milovanovic M, et al
    Yield of facility-based targeted universal testing for tuberculosis (TUTT) with Xpert and mycobacterial culture in high-risk groups attending primary care facilities in South Africa.
    Clin Infect Dis. 2023 Jan 5:ciac965. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. SOLANS BP, Beranger A, Radtke K, Mohamed A, et al
    Effectiveness and pharmacokinetic exposures of first-line drugs used to treat drug-susceptible tuberculosis in children: a systematic review and meta-analysis.
    Clin Infect Dis. 2023 Jan 4:ciac973. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2022
76. DANIEL EA, Thiruvengadam K, Rajamanickam A, Chandrasekaran P, et al
    QuantiFERON supernatant-based host biomarkers predicting progression to active tuberculosis disease among household contacts of tuberculosis patients.
    Clin Infect Dis. 2022 Dec 30:ciac979. doi: 10.1093.
    PubMed     Abstract available
    
    
    
77. LEE HR, Yoo JE, Choi H, Han K, et al
    Tuberculosis and the Risk of Ischemic Heart Disease: A Nationwide Cohort Study.
    Clin Infect Dis. 2022 Dec 15:ciac946. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. DAVIS AG, Wasserman S, Stek C, Maxebengula M, et al
    A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial).
    Clin Infect Dis. 2022 Dec 9:ciac932. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. HANRAHAN CF, Nonyane BAS, Lebina L, Mmolawa L, et al
    Household versus incentive-based contact investigation for tuberculosis in rural South Africa: a cluster-randomized trial.
    Clin Infect Dis. 2022 Dec 2:ciac920. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2022
80. SINHA P, Ponnuraja C, Gupte N, Babu SP, et al
    Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter Prospective Cohort Analysis.
    Clin Infect Dis. 2022 Nov 25:ciac915. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. FLEXNER C, Siccardi M, Bunglawala F, Owen A, et al
    The LEAP Process: Streamlining the Development of Long-Acting Products and Formulations for Infectious Diseases.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available
    
    
    
82. AMMERMAN NC, Nuermberger EL, Owen A, Rannard SP, et al
    Potential Impact of Long-Acting Products on the Control of Tuberculosis: Preclinical Advancements and Translational Tools in Preventive Treatment.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available
    
    
    
83. BROWN RIPIN DH, Catlin K, Lewis L, Resar D, et al
    Transitioning Long-Acting Products to a Generic Marketplace: What's Missing?
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available
    
    
    
84. WILLIAMS CM, Muhammad AK, Sambou B, Bojang A, et al
    Exhaled Mycobacterium tuberculosis Predicts Incident Infection in Household Contacts.
    Clin Infect Dis. 2022 Nov 9. pii: 6815639. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. HOLMGAARD FB, Guglielmetti L, Lillebaek T, Andersen AB, et al
    Efficacy and tolerability of concomitant use of bedaquiline and delamanid for multidrug- and extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Clin Infect Dis. 2022 Nov 4. pii: 6801118. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. NDEGE R, Ngome O, Vanobberghen F, Bani F, et al
    Ultrasound in managing extrapulmonary tuberculosis: A randomised, controlled, parallel, superiority, open-label trial.
    Clin Infect Dis. 2022 Nov 4. pii: 6801068. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. LOUIE JK, Keh C, Agraz-Lara R, Phillips A, et al
    Adverse Events Associated with Treatment for Pan-susceptible Tuberculosis in San Francisco.
    Clin Infect Dis. 2022 Nov 2. pii: 6793979. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
88. DAVIS AG, Dreyer AJ, Albertyn C, Maxebengula M, et al
    Cognitive Impairment in Tuberculous Meningitis.
    Clin Infect Dis. 2022 Oct 20. pii: 6763738. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2022
89. HEWISON C, Khan U, Bastard M, Lachenal N, et al
    Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
    Clin Infect Dis. 2022;75:1006-1013.
    PubMed     Abstract available
    
    
    
90. KAIPILYAWAR V, Zhao Y, Wang X, Joseph NM, et al
    Development and Validation of a Parsimonious Tuberculosis Gene Signature Using the digital NanoString nCounter Platform.
    Clin Infect Dis. 2022;75:1022-1030.
    PubMed     Abstract available
    
    
    
91. EOM JS, Park S, Jang H, Kim S, et al
    Bronchial washing using a thin versus a thick bronchoscope to diagnose pulmonary tuberculosis: A randomized trial.
    Clin Infect Dis. 2022 Sep 24. pii: 6713550. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. BALIASHVILI D, Blumberg HM, Benkeser D, Kempker RR, et al
    Association of treated and untreated chronic hepatitis C with the incidence of active tuberculosis disease: a population-based cohort study.
    Clin Infect Dis. 2022 Sep 22. pii: 6711147. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. HUANG HL, Lee JY, Lo YS, Liu IH, et al
    Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy.
    Clin Infect Dis. 2022;75:743-752.
    PubMed     Abstract available
    
    
    
94. KAY A, Reyes JM, Devezin T, Bakaya M, et al
    Optimal timing of antiretroviral therapy initiation in children and adolescents with HIV-associated pulmonary tuberculosis.
    Clin Infect Dis. 2022 Sep 13. pii: 6696609. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
95. PETTIT AC, Phillips PP, Kurbatova E, Vernon A, et al
    Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349).
    Clin Infect Dis. 2022 Aug 30. pii: 6679254. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. KAGUJJE M, Kerkhoff AD, Nteeni M, Dunn I, et al
    The performance of computer-aided detection digital chest X-ray reading technologies for triage of active Tuberculosis among persons with a history of previous Tuberculosis.
    Clin Infect Dis. 2022 Aug 25. pii: 6675069. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. MARQUEZ C, Chen Y, Atukunda M, Chamie G, et al
    The Association Between Social Network Characteristics and Tuberculosis Infection Among Adults in Nine Rural Ugandan Communities.
    Clin Infect Dis. 2022 Aug 19. pii: 6671580. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2022
98. GASKELL KM, Pillay TD, Brown J, Belton M, et al
    Latent tuberculosis infection care.
    Clin Infect Dis. 2022 Jul 23. pii: 6649071. doi: 10.1093.
    PubMed    
    
    
    
99. SEKAGGYA-WILTSHIRE C, Nabisere R, Musaazi J, Otaalo B, et al
    Decreased dolutegravir and efavirenz concentrations with preserved virological suppression in patients with TB and HIV receiving high-dose rifampicin.
    Clin Infect Dis. 2022 Jul 21. pii: 6647783. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. SANDS A, Santiago MT, Uduwana S, Glater-Welt L, et al
     Congenital Tuberculosis after In-vitro Fertilization: A Case for Tuberculosis Screening of Women Evaluated for Infertility.
     Clin Infect Dis. 2022 Jul 5. pii: 6629411. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. PILLAY S, de Vos M, Derendinger B, Streicher E, et al
     Non-actionable results, accuracy and effect of the first- and second-line line probe assays for diagnosing drug resistant tuberculosis, including on smear-negative specimens, in a high-volume laboratory.
     Clin Infect Dis. 2022 Jul 5. pii: 6631215. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. RIDOLFI F, Peetluk L, Amorim G, Turner M, et al
     TB TREATMENT OUTCOMES IN BRAZIL: DIFFERENT PREDICTORS FOR EACH TYPE OF UNSUCCESSFUL OUTCOME.
     Clin Infect Dis. 2022 Jul 5. pii: 6631480. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2022
103. PADMAPRIYADARSINI C, Vohra V, Bhatnagar A, Solanki R, et al
     Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.
     Clin Infect Dis. 2022 Jun 29. pii: 6619622. doi: 10.1093.
     PubMed     Abstract available
     
     
     
104. HEYSELL SK, Mpagama SG, Ogarkov OB, Conaway M, et al
     Pharmacokinetic-pharmacodynamic determinants of clinical outcomes for rifampin-resistant tuberculosis: a multi-site prospective cohort study.
     Clin Infect Dis. 2022 Jun 22. pii: 6613372. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. MATHAD JS, Queiroz ATL, Bhosale R, Alexander M, et al
     Transcriptional analysis for tuberculosis in pregnant women from the PRACHITi study.
     Clin Infect Dis. 2022 Jun 10. pii: 6605083. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. HORSBURGH CR, Jo Y, Nichols B, Jenkins HE, et al
     The contribution of reinfection to annual rate of tuberculosis infection (ARI) and incidence of TB disease.
     Clin Infect Dis. 2022 Jun 6. pii: 6603293. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2022
107. CHOI H, Han K, Jung JH, Park SH, et al
     Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study.
     Clin Infect Dis. 2022 May 25. pii: 6591843. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. LACOURSE SM, Escudero JN, Mecha J, Warr AJ, et al
     Cumulative Mtb infection incidence (measured primarily by TST) among infants with HIV exposure: observational follow-up of an isoniazid prophylaxis trial.
     Clin Infect Dis. 2022 May 24. pii: 6590981. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. COX H, Workman L, Bateman L, Franckling-Smith Z, et al
     Oral swabs tested with Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in children: a diagnostic accuracy study.
     Clin Infect Dis. 2022 May 17. pii: 6586837. doi: 10.1093.
     PubMed     Abstract available
     
     
     
110. LE V, Pascopella L, Westenhouse J, Barry P, et al
     A cross-sectional study of patients with extrapulmonary tuberculosis and normal chest radiographs - what characteristics were associated with sputum culture positivity?
     Clin Infect Dis. 2022 May 6. pii: 6581570. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2022
111. PODELL BK, Aibana O, Huang CC, DiLisio JE, et al
     The Impact of Vitamin A Deficiency on Tuberculosis Progression.
     Clin Infect Dis. 2022 Apr 29. pii: 6576158. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. GOVENDER I, Karat AS, Olivier S, Baisley K, et al
     Correction to: Prevalence of Mycobacterium tuberculosis in Sputum and Reported Symptoms Among Clinic Attendees Compared With a Community Survey in Rural South Africa.
     Clin Infect Dis. 2022 Apr 27. pii: 6574994. doi: 10.1093.
     PubMed    
     
     
     
113. CAMPBELL JR, Chan ED, Falzon D, Trajman A, et al
     Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis.
     Clin Infect Dis. 2022 Apr 27. pii: 6574751. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. HUGHES JA, Solans BP, Draper HR, Schaaf HS, et al
     Pharmacokinetics and Safety of Bedaquiline in HIV-Positive and Negative Older Children and Adolescents with Rifampicin-Resistant Tuberculosis.
     Clin Infect Dis. 2022 Apr 4. pii: 6563170. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. HOLZMAN SB, Perry A, Saleeb P, Pyan A, et al
     Evaluation of the latent tuberculosis care cascade among public health clinics in the United States.
     Clin Infect Dis. 2022 Apr 1. pii: 6562172. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2022
116. NATHELLA PK, Moideen K, Viswanathan V, Sivakumar S, et al
     Heightened microbial translocation is a prognostic biomarker of recurrent tuberculosis.
     Clin Infect Dis. 2022 Mar 30. pii: 6555776. doi: 10.1093.
     PubMed     Abstract available
     
     
     
117. BATEMAN M, Wolf A, Chimukangara B, Brust JCM, et al
     Adherence measured using electronic dose monitoring is associated with emergent antiretroviral resistance and poor outcomes in patients co-infected with HIV/AIDS and multidrug-resistant tuberculosis.
     Clin Infect Dis. 2022 Mar 30. pii: 6555759. doi: 10.1093.
     PubMed     Abstract available
     
     
     
118. NATHAVITHARANA RR, Mishra H, Sullivan A, Hurwitz S, et al
     Predicting airborne infection risk: Association between personal ambient carbon dioxide level monitoring and incidence of tuberculosis infection in South African health workers.
     Clin Infect Dis. 2022 Mar 26. pii: 6554598. doi: 10.1093.
     PubMed     Abstract available
     
     
     
119. MCCALLUM AD, Pertinez HE, Chirambo AP, Sheha I, et al
     High intrapulmonary rifampicin and isoniazid concentrations are associated with rapid sputum bacillary clearance in patients with pulmonary tuberculosis.
     Clin Infect Dis. 2022 Mar 23. pii: 6553299. doi: 10.1093.
     PubMed     Abstract available
     
     
     
120. PARADKAR MS, Devaleenal DB, Mvalo T, Arenivas A, et al
     Randomized Clinical Trial of High Dose Rifampicin with or without Levofloxacin versus Standard of Care for Paediatric Tuberculous Meningitis: The TBM-KIDS Trial.
     Clin Infect Dis. 2022 Mar 15. pii: 6549152. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. NAIDOO K, Moodley MC, Hassan-Moosa R, Dookie N, et al
     Recurrent subclinical tuberculosis among ART accessing participants: Incidence, clinical course, and outcomes.
     Clin Infect Dis. 2022 Mar 5. pii: 6542969. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. HUERGA H, Khan U, Bastard M, Mitnick CD, et al
     Safety and effectiveness outcomes from a 14-country cohort of patients with multi-drug resistant tuberculosis treated concomitantly with bedaquiline, delamanid and other second-line drugs.
     Clin Infect Dis. 2022 Mar 4. pii: 6542212. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2022
123. SHRESTHA S, Winglee K, Hill A, Shaw T, et al
     Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state-level differences across California, Florida, New York, and Texas.
     Clin Infect Dis. 2022 Feb 10. pii: 6526443. doi: 10.1093.
     PubMed     Abstract available
     
     
     
124. BERANGER A, Bekker A, Solans BP, Cotton MF, et al
     Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure.
     Clin Infect Dis. 2022 Feb 4. pii: 6522054. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2022
125. PALMER M, Gunasekera KS, van der Zalm MM, Morrison J, et al
     The diagnostic accuracy of chest radiographic features for pediatric intrathoracic tuberculosis.
     Clin Infect Dis. 2022 Jan 7. pii: 6500009. doi: 10.1093.
     PubMed     Abstract available
     
     
     
126. MAVE V, Chen L, Ranganathan UD, Kadam D, et al
     Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India.
     Clin Infect Dis. 2022 Jan 4. pii: 6497515. doi: 10.1093/cid/ciab1067.
     PubMed     Abstract available
     
     
     
127. STUCK L, van Haaster AC, Kapata-Chanda P, Klinkenberg E, et al
     How 'subclinical' is subclinical tuberculosis? An analysis of national prevalence survey data from Zambia.
     Clin Infect Dis. 2022 Jan 4. pii: 6497425. doi: 10.1093/cid/ciab1050.
     PubMed     Abstract available
     
     
     December 2021
128. LI H, Chee CBE, Geng T, Pan A, et al
     Joint associations of multiple lifestyle factors with risk of active tuberculosis in the population: the Singapore Chinese Health Study.
     Clin Infect Dis. 2021 Dec 27. pii: 6484917. doi: 10.1093.
     PubMed     Abstract available
     
     
     
129. MARTINSON NA, Lebina L, Webb EL, Ratsela A, et al
     Household contact tracing with intensified tuberculosis and HIV screening in South Africa: a cluster randomised trial.
     Clin Infect Dis. 2021 Dec 24. pii: 6482200. doi: 10.1093/cid/ciab1047.
     PubMed     Abstract available
     
     
     
130. KHALIFE S, Jenkins HE, Dolynska M, Terleieva I, et al
     Incidence and Mortality of Extrapulmonary Tuberculosis in Ukraine: Analysis of National Surveillance Data.
     Clin Infect Dis. 2021 Dec 20. pii: 6470933. doi: 10.1093/cid/ciab1018.
     PubMed     Abstract available
     
     
     
131. PODANY AT, Pham M, Sizemore E, Martinson N, et al
     Efavirenz pharmacokinetics and HIV-1 viral suppression among patients receiving TB treatment containing daily high-dose rifapentine.
     Clin Infect Dis. 2021 Dec 16. pii: 6464327. doi: 10.1093/cid/ciab1037.
     PubMed     Abstract available
     
     
     
132. SINHA P, Lakshminarayanan SL, Cintron C, Narasimhan PB, et al
     Nutritional Supplementation Would Be Cost-Effective for Reducing Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) model.
     Clin Infect Dis. 2021 Dec 15. pii: 6462896. doi: 10.1093/cid/ciab1033.
     PubMed     Abstract available
     
     
     
133. GAFAR F, Marais BJ, Nataprawira HM, Alffenaar JC, et al
     Optimizing antimicrobial and host-directed therapies to improve clinical outcomes of childhood tuberculous meningitis.
     Clin Infect Dis. 2021 Dec 15. pii: 6463307. doi: 10.1093/cid/ciab1036.
     PubMed    
     
     
     
134. HAMILTON CD
     Who Knew? Injectable TB Drugs Are Not Equal, Despite Drug Susceptibility Testing.
     Clin Infect Dis. 2021;73:e3937-e3938.
     PubMed    
     
     
     
135. MOED S, Suprenant M, Odjidja EN, Meguid T, et al
     Economic Evaluation of Screening Interventions for Drug-induced Liver Injury.
     Clin Infect Dis. 2021;73:e3959-e3965.
     PubMed     Abstract available
     
     
     
136. GOVENDER I, Karat AS, Olivier S, Baisley K, et al
     Prevalence of Mycobacterium tuberculosis in sputum and reported symptoms among clinic attendees compared to a community survey in rural South Africa.
     Clin Infect Dis. 2021 Dec 3. pii: 6433207. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2021
137. KEMPKER RR, Smith AGC, Avaliani T, Gujabidze M, et al
     Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness.
     Clin Infect Dis. 2021 Nov 29. pii: 6446239. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. THEE S, Basu Roy R, Blazquez-Gamero D, Falcon-Neyra L, et al
     Treatment and outcome in children with tuberculous meningitis - a multi-centre Paediatric Tuberculosis Network European Trials Group study.
     Clin Infect Dis. 2021 Nov 27. pii: 6444805. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. PADMAPRIYDARSINI C, Mamulwar M, Mohan A, Shanmugam P, et al
     Randomized trial of Metformin with Anti-tuberculosis drugs For Early Sputum Conversion in Adults with Pulmonary Tuberculosis.
     Clin Infect Dis. 2021 Nov 26. pii: 6444297. doi: 10.1093.
     PubMed     Abstract available
     
     
     
140. VELEN K, Nhung NV, Anh NT, Cuong PD, et al
     Risk Factors for Tuberculosis (TB) Among Household Contacts of Patients With Smear-Positive TB in 8 Provinces of Vietnam: A Nested Case-Control Study.
     Clin Infect Dis. 2021;73:e3358-e3364.
     PubMed     Abstract available
     
     
     
141. DAS M, Dalal A, Laxmeshwar C, Ravi S, et al
     One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India.
     Clin Infect Dis. 2021;73:e3496-e3504.
     PubMed     Abstract available
     
     
     
142. HALEY C, Rowlinson MC, Ashkin D
     Tuberculosis Therapy: "In Pursuit of Perfection".
     Clin Infect Dis. 2021;73:e3529-e3530.
     PubMed    
     
     
     October 2021
143. DOS SANTOS PCP, da Silva Santos A, de Oliveira RD, da Silva BO, et al
     Pooling Sputum Samples for Efficient Mass Tuberculosis Screening in Prisons.
     Clin Infect Dis. 2021 Oct 28. pii: 6413467. doi: 10.1093.
     PubMed     Abstract available
     
     
     
144. KUMAR GS, Pezzi C, Payton C, Mamo B, et al
     Health of Asylees Compared to Refugees in the United States Using Domestic Medical Examination Data, 2014-2016: A Cross-Sectional Analysis.
     Clin Infect Dis. 2021;73:1492-1499.
     PubMed     Abstract available
     
     
     
145. DENTI P, Wasmann RE, van Rie A, Winckler J, et al
     Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: a prospective population pharmacokinetic study.
     Clin Infect Dis. 2021 Oct 19. pii: 6403131. doi: 10.1093.
     PubMed     Abstract available
     
     
     
146. HUANG W, Chiu NC, Chi H, Huang FY, et al
     Inoculation Age of Bacillus Calmette-Guerin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
     Clin Infect Dis. 2021;73:e1554-e1559.
     PubMed     Abstract available
     
     
     
147. MACLEAN E, Dendukuri N
     Latent Class Analysis and the Need for Clear Reporting of Methods.
     Clin Infect Dis. 2021;73:e2285-e2286.
     PubMed    
     
     
     
148. IMPERIAL MZ, Nedelman JR, Conradie F, Savic RM, et al
     Proposed linezolid dosing strategies to minimize adverse events for treatment of extensively drug-resistant tuberculosis.
     Clin Infect Dis. 2021 Oct 4. pii: 6380680. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2021
149. SUTHERLAND JS, van der Spuy G, Gindeh A, Thuong NT, et al
     Diagnostic accuracy of the Cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results.
     Clin Infect Dis. 2021 Sep 22. pii: 6373967. doi: 10.1093.
     PubMed     Abstract available
     
     
     
150. OLOMI W, Biraro IA, Kilonzo K, Te Brake L, et al
     Tuberculosis preventive therapy for people with diabetes mellitus.
     Clin Infect Dis. 2021 Sep 10. pii: 6368159. doi: 10.1093.
     PubMed    
     
     
     
151. ACHARYA MP, Pradeep SP, Murthy VS, Chikkannaiah P, et al
     CD38+CD27-TNF-alpha + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis.
     Clin Infect Dis. 2021;73:793-801.
     PubMed     Abstract available
     
     
     August 2021
152. MARTINEZ L, Ncayiyana JR, Goddard L, Botha M, et al
     Vitamin D concentrations in infancy and the risk of tuberculosis in childhood: A prospective birth cohort in Cape Town, South Africa.
     Clin Infect Dis. 2021 Aug 26. pii: 6358095. doi: 10.1093.
     PubMed     Abstract available
     
     
     
153. NWONGBOUWOH MUEFONG C, Owolabi O, Donkor S, Charalambous S, et al
     Neutrophils contribute to severity of tuberculosis pathology and recovery from lung damage pre- and post-treatment.
     Clin Infect Dis. 2021 Aug 24. pii: 6356988. doi: 10.1093.
     PubMed     Abstract available
     
     
     
154. CHABALA C, Turkova A, Hesseling AC, Zimba KM, et al
     Pharmacokinetics of first-line drugs in children with tuberculosis using WHO-recommended weight band doses and formulations.
     Clin Infect Dis. 2021 Aug 22. pii: 6356214. doi: 10.1093.
     PubMed     Abstract available
     
     
     
155. FRITSCHI N, Wind A, Hammer J, Ritz N, et al
     Subclinical tuberculosis in children: diagnostic strategies for identification reported in a 6-year national prospective surveillance study.
     Clin Infect Dis. 2021 Aug 19. pii: 6354867. doi: 10.1093.
     PubMed     Abstract available
     
     
     
156. LEWIS JM, Mphasa M, Keyala L, Banda R, et al
     A longitudinal observational study of aetiology and long-term outcomes of sepsis in Malawi revealing the key role of disseminated tuberculosis.
     Clin Infect Dis. 2021 Aug 18. pii: 6354427. doi: 10.1093.
     PubMed     Abstract available
     
     
     
157. BURKE RM, Gupta Wright A
     Diagnosing Tuberculosis in People With Advanced Human Immunodeficiency Virus: More Is Needed.
     Clin Infect Dis. 2021;73:e878-e879.
     PubMed    
     
     
     
158. MATOGA MM, Bisson GP, Gupta A, Miyahara S, et al
     Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.
     Clin Infect Dis. 2021;73:e870-e877.
     PubMed     Abstract available
     
     
     
159. KENDALL MA, Lalloo U, Fletcher CV, Wu X, et al
     Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection.
     Clin Infect Dis. 2021;73:706-715.
     PubMed     Abstract available
     
     
     July 2021
160. KIM S, Cohen T, Horsburgh CR, Miller JW, et al
     Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States.
     Clin Infect Dis. 2021 Jul 29. pii: 6330597. doi: 10.1093.
     PubMed     Abstract available
     
     
     
161. MATHAD JS, Savic R, Britto P, Jayachandran P, et al
     Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
     Clin Infect Dis. 2021 Jul 29. pii: 6330598. doi: 10.1093.
     PubMed     Abstract available
     
     
     
162. MOODLEY N, Velen K, Saimen A, Zakhura N, et al
     Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa.
     Clin Infect Dis. 2021 Jul 27. pii: 6329140. doi: 10.1093.
     PubMed     Abstract available
     
     
     
163. KAY AW, Sandoval M, Mtetwa G, Mkhabela M, et al
     Vikela Ekhaya: a novel, community-based, tuberculosis contact management program in a high burden setting.
     Clin Infect Dis. 2021 Jul 24. pii: 6327779. doi: 10.1093.
     PubMed     Abstract available
     
     
     
164. RADTKE KK, Hesseling AC, Winckler JL, Draper HR, et al
     Moxifloxacin pharmacokinetics, cardiac safety, and dosing for the treatment of rifampicin-resistant tuberculosis in children.
     Clin Infect Dis. 2021 Jul 21. pii: 6324883. doi: 10.1093.
     PubMed     Abstract available
     
     
     
165. TAVAZIVA G, Harris M, Abidi SK, Geric C, et al
     Chest X-ray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: an individual patient data meta-analysis of diagnostic accuracy.
     Clin Infect Dis. 2021 Jul 21. pii: 6324830. doi: 10.1093.
     PubMed     Abstract available
     
     
     
166. WEIR IR, Wasserman S
     Treatment effect measures for culture conversion endpoints in phase IIb tuberculosis treatment trials.
     Clin Infect Dis. 2021 Jul 13. pii: 6319902. doi: 10.1093.
     PubMed     Abstract available
     
     
     
167. PEETLUK LS, Rebeiro PF, Ridolfi FM, Andrade BB, et al
     A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes.
     Clin Infect Dis. 2021 Jul 2. pii: 6313211. doi: 10.1093.
     PubMed     Abstract available
     
     
     
168. BAIK Y, Hanrahan CF, Mmolawa L, Nonyane BAS, et al
     Conditional cash transfers to incentivize tuberculosis screening: Description of a novel strategy for contact investigation in rural South Africa.
     Clin Infect Dis. 2021 Jul 2. pii: 6312933. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2021
169. CHU AL, Murray MB, Huang CC
     Potential role of latent tuberculosis infection in the pathophysiology of cardiovascular disease.
     Clin Infect Dis. 2021 Jun 28. pii: 6310818. doi: 10.1093.
     PubMed    
     
     
     
170. CEGIELSKI JP, Udwadia ZF, Viiklepp P, Yim JJ, et al
     Reply to van Deun and Decroo.
     Clin Infect Dis. 2021;72:e1168-e1169.
     PubMed    
     
     
     
171. CHIDAMBARAM V, Tun NL, Majella MG, Ruelas Castillo J, et al
     Male sex is associated with worse microbiological and clinical outcomes following tuberculosis treatment: A retrospective cohort study, a systematic review of the literature, and meta-analysis.
     Clin Infect Dis. 2021 Jun 8. pii: 6294896. doi: 10.1093.
     PubMed     Abstract available
     
     
     
172. LU P, Liu Q, Zhou Y, Martinez L, et al
     Predictors of Discordant Tuberculin Skin Test and QuantiFERON-TB Gold In-tube Results in Eastern China: A Population-based, Cohort Study.
     Clin Infect Dis. 2021;72:2006-2015.
     PubMed     Abstract available
     
     
     May 2021
173. CHU AL, Lecca LW, Calderon RI, Contreras CC, et al
     Smoking cessation in tuberculosis patients and the risk of tuberculosis infection in child household contacts.
     Clin Infect Dis. 2021 May 28. pii: 6287936. doi: 10.1093.
     PubMed     Abstract available
     
     
     
174. XU M, Lu W, Li T, Li J, et al
     Sensitivity, specificity, and safety of a novel ESAT6-CFP10 skin test for tuberculosis infection in China: two randomized, self-controlled, parallel-group phase 2b trials.
     Clin Infect Dis. 2021 May 22. pii: 6280234. doi: 10.1093.
     PubMed     Abstract available
     
     
     
175. LEE H, Myung W, Lee EM, Kim H, et al
     Mortality and Prognostic Factors of Nontuberculous Mycobacterial Infection in Korea: A Population-based Comparative Study.
     Clin Infect Dis. 2021;72:e610-e619.
     PubMed     Abstract available
     
     
     
176. MALIK AA, Becerra MC, Lash TL, Cranmer LM, et al
     Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis Exposure.
     Clin Infect Dis. 2021;72:1709-1715.
     PubMed     Abstract available
     
     
     
177. NARITA M, Hatt G, Toren KG, Vuong K, et al
     Delayed Tuberculosis Diagnoses During the COVID-19 Pandemic in 2020 - King County, Washington.
     Clin Infect Dis. 2021 May 6. pii: 6270740. doi: 10.1093.
     PubMed    
     
     
     
178. MARAIS BJ
     Improved Urine Lipoarabinomannan (LAM) Tests: The Answer for Child Tuberculosis Diagnosis?
     Clin Infect Dis. 2021;72:e289-e290.
     PubMed    
     
     
     April 2021
179. GROBBEL HP, Merker M, Kohler N, Andres S, et al
     Design of multidrug-resistant tuberculosis treatment regimens based on DNA sequencing.
     Clin Infect Dis. 2021 Apr 26. pii: 6253713. doi: 10.1093.
     PubMed     Abstract available
     
     
     
180. BRUST JCM, Gandhi NR, Wasserman S, Maartens G, et al
     Effectiveness and cardiac safety of bedaquiline-based therapy for drug-resistant tuberculosis: a prospective cohort study.
     Clin Infect Dis. 2021 Apr 21. pii: 6244470. doi: 10.1093.
     PubMed     Abstract available
     
     
     
181. HWANG H, Kang H, Kwon YS, Jeon D, et al
     Outcomes of multidrug-resistant tuberculosis treated with bedaquiline or delamanid.
     Clin Infect Dis. 2021 Apr 10. pii: 6219782. doi: 10.1093.
     PubMed     Abstract available
     
     
     
182. MARAIS BJ
     Good Outcomes in Babies With In Utero Bedaquiline Exposure.
     Clin Infect Dis. 2021;72:1169-1170.
     PubMed    
     
     
     March 2021
183. BALIASHVILI D, Gandhi NR, Kim S, Hughes M, et al
     Resistance to Mycobacterium tuberculosis infection among household contacts: a multinational study.
     Clin Infect Dis. 2021 Mar 27. pii: 6193424. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. ADU-GYAMFI C, Savulescu D, Mikhathani L, Otwombe K, et al
     Plasma kynurenine-to-tryptophan ratio, a highly sensitive blood-based diagnostic tool for Tuberculosis in HIV-infected pregnant women.
     Clin Infect Dis. 2021 Mar 15. pii: 6170938. doi: 10.1093.
     PubMed     Abstract available
     
     
     
185. CRESSWELL FV, Meya DB, Kagimu E, Grint D, et al
     High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly HIV-positive Ugandan adults: a phase II open-label randomised controlled trial.
     Clin Infect Dis. 2021 Mar 8. pii: 6159697. doi: 10.1093.
     PubMed     Abstract available
     
     
     
186. HUANG HL, Huang WC, Lin KD, Liu SS, et al
     Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients with Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study.
     Clin Infect Dis. 2021 Mar 3. pii: 6157057. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2021
187. BURKE RM, Gupta Wright A
     Diagnosing tuberculosis in people with advanced HIV: more is needed.
     Clin Infect Dis. 2021 Feb 26. pii: 6152006. doi: 10.1093.
     PubMed    
     
     
     
188. ACHARYA MP, Pradeep SP, Murthy VS, Chikkannaiah P, et al
     CD38 +CD27 -TNF-alpha + on Mtb-specific CD4 + T is a robust biomarker for tuberculosis diagnosis.
     Clin Infect Dis. 2021 Feb 19. pii: 6144985. doi: 10.1093.
     PubMed     Abstract available
     
     
     
189. SAM-AGUDU NA, Rabie H, Pipo MT, Byamungu LN, et al
     The Critical Need for Pooled Data on COVID-19 in African Children: An AFREhealth Call for Action through Multi-Country Research Collaboration.
     Clin Infect Dis. 2021 Feb 13. pii: 6134449. doi: 10.1093.
     PubMed     Abstract available
     
     
     
190. DU PREEZ K, Osman M, Seddon JA, Naidoo P, et al
     The impact of the evolving HIV response on the epidemiology of tuberculosis in South African children and adolescents.
     Clin Infect Dis. 2021 Feb 3. pii: 6127007. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2021
191. GUNASEKERA KS, Walters E, van der Zalm MM, Palmer M, et al
     Development of a treatment-decision algorithm for HIV-uninfected children evaluated for pulmonary tuberculosis.
     Clin Infect Dis. 2021 Jan 15. pii: 6101512. doi: 10.1093.
     PubMed     Abstract available
     
     
     
192. BROGER T, Nicol MP
     A novel bedside rule-in test for tuberculous meningitis in HIV-infected adults.
     Clin Infect Dis. 2021 Jan 6. pii: 6065103. doi: 10.1093/cid/ciaa1915.
     PubMed    
     
     
     
193. HUAMAN MA, De Cecco CN, Bittencourt MS, Ticona E, et al
     Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda.
     Clin Infect Dis. 2021 Jan 3. pii: 6060062. doi: 10.1093/cid/ciaa1934.
     PubMed     Abstract available
     
     
     
194. QUINN CM, Kagimu E, Okirworth M, Bangdiwala AS, et al
     Fujifilm SILVAMP TB LAM assay on cerebrospinal fluid for the detection of tuberculous meningitis in HIV-infected adults.
     Clin Infect Dis. 2021 Jan 3. pii: 6059780. doi: 10.1093/cid/ciaa1910.
     PubMed     Abstract available
     
     
     December 2020
195. TACK I, Dumicho A, Ohler L, Shigayeva A, et al
     Safety and effectiveness of an all-oral, bedaquiline-based, shorter treatment regimen for rifampicin-resistant tuberculosis in high HIV burden rural South Africa: a retrospective cohort analysis.
     Clin Infect Dis. 2020 Dec 29. pii: 6054965. doi: 10.1093/cid/ciaa1894.
     PubMed     Abstract available
     
     
     
196. VAN DEUN A, Decroo T
     How second-line injectable drugs work.
     Clin Infect Dis. 2020 Dec 20. pii: 6042343. doi: 10.1093/cid/ciaa1874.
     PubMed    
     
     
     
197. YUEN CM, Majidulla A, Jaswal M, Safdar N, et al
     Cost of delivering 12-dose isoniazid and rifapentine versus 6 months of isoniazid for tuberculosis infection in a high-burden setting.
     Clin Infect Dis. 2020 Dec 8. pii: 6025518. doi: 10.1093/cid/ciaa1835.
     PubMed     Abstract available
     
     
     
198. OH CE, Ortiz-Brizuela E, Bastos ML, Menzies D, et al
     Comparing the Diagnostic Performance of QFT-Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
     Clin Infect Dis. 2020 Dec 8. pii: 6026460. doi: 10.1093/cid/ciaa1822.
     PubMed     Abstract available
     
     
     
199. DONOVAN J, Oanh PKN, Dobbs N, Phu NH, et al
     Optic nerve sheath ultrasound for the detection and monitoring of raised intracranial pressure in tuberculous meningitis.
     Clin Infect Dis. 2020 Dec 7. pii: 6025000. doi: 10.1093/cid/ciaa1823.
     PubMed     Abstract available
     
     
     
200. KENDALL EA, Kitonsa PJ, Nalutaaya A, Kamoga CE, et al
     The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities.
     Clin Infect Dis. 2020 Dec 6. pii: 6024999. doi: 10.1093/cid/ciaa1824.
     PubMed     Abstract available
     
     
     
201. WONG EB
     It is time to focus on asymptomatic tuberculosis.
     Clin Infect Dis. 2020 Dec 6. pii: 6024996. doi: 10.1093/cid/ciaa1827.
     PubMed    
     
     
     
202. VAN TOORN R, Solomons RS, Seddon JA, Schoeman JF, et al
     Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort.
     Clin Infect Dis. 2020 Dec 6. pii: 6024997. doi: 10.1093/cid/ciaa1826.
     PubMed     Abstract available
     
     
     November 2020
203. ASABOR EN, Vermund SH
     Confronting structural racism in the prevention and control of tuberculosis in the United States.
     Clin Infect Dis. 2020 Nov 26. pii: 6006871. doi: 10.1093/cid/ciaa1763.
     PubMed     Abstract available
     
     
     
204. HUANG HL, Lee MR, Cheng MH, Lu PL, et al
     Impact of age on outcome of rifapentine-based weekly therapy for latent tuberculosis infection.
     Clin Infect Dis. 2020 Nov 19. pii: 5992466. doi: 10.1093/cid/ciaa1741.
     PubMed     Abstract available
     
     
     
205. REDDY KP, Denkinger CM, Broger T, McCann NC, et al
     Cost-effectiveness of a novel lipoarabinomannan test for tuberculosis in patients with HIV.
     Clin Infect Dis. 2020 Nov 17. pii: 5983890. doi: 10.1093/cid/ciaa1698.
     PubMed     Abstract available
     
     
     
206. MONTEPIEDRA G, Kim S, Weinberg A, Theron G, et al
     Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women.
     Clin Infect Dis. 2020 Nov 4. pii: 5955952. doi: 10.1093/cid/ciaa1674.
     PubMed     Abstract available
     
     
     
207. COLLINS JM, Stout JE, Ayers T, Hill AN, et al
     Prevalence of Latent Tuberculosis Infection among Non-U.S.-Born Persons by Country of Birth - United States, 2012-2017.
     Clin Infect Dis. 2020 Nov 2. pii: 5952274. doi: 10.1093/cid/ciaa1662.
     PubMed     Abstract available
     
     
     October 2020
208. CEGIELSKI JP, Chan PC, Lan Z, Udwadia ZF, et al
     Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016.
     Clin Infect Dis. 2020 Oct 30. pii: 5943503. doi: 10.1093.
     PubMed     Abstract available
     
     
     
209. ZHENG X, Bao Z, Forsman LD, Hu Y, et al
     Drug exposure and minimum inhibitory concentration predict pulmonary tuberculosis treatment response.
     Clin Infect Dis. 2020 Oct 18. pii: 5929670. doi: 10.1093/cid/ciaa1569.
     PubMed     Abstract available
     
     
     
210. KAKAIRE R, Kiwanuka N, Zalwango S, Sekandi JN, et al
     Excess Risk of Tuberculous Infection among Extra-Household Contacts of Tuberculosis Cases in an African City.
     Clin Infect Dis. 2020 Oct 16. pii: 5925052. doi: 10.1093/cid/ciaa1556.
     PubMed     Abstract available
     
     
     
211. DUFFY D, Nemes E, Llibre A, Rouilly V, et al
     Immune profiling enables stratification of patients with active TB disease or M. tuberculosis infection.
     Clin Infect Dis. 2020 Oct 16. pii: 5924452. doi: 10.1093/cid/ciaa1562.
     PubMed     Abstract available
     
     
     
212. ZELNICK JR, Daftary A, Hwang C, Labar AS, et al
     Electronic dose monitoring identifies a high-risk subpopulation in the treatment of drug-resistant tuberculosis and HIV.
     Clin Infect Dis. 2020 Oct 14. pii: 5923372. doi: 10.1093/cid/ciaa1557.
     PubMed     Abstract available
     
     
     
213. KUHLIN J, Davies Forsman L, Mansjo M, Jonsson Nordvall M, et al
     Genotypic resistance of pyrazinamide but not MIC is associated with longer time to sputum culture conversion in patients with multidrug-resistant tuberculosis.
     Clin Infect Dis. 2020 Oct 3. pii: 5917759. doi: 10.1093/cid/ciaa1509.
     PubMed     Abstract available
     
     
     September 2020
214. THERON G, Montepiedra G, Aaron L, McCarthy K, et al
     Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV.
     Clin Infect Dis. 2020 Sep 30. pii: 5913421. doi: 10.1093/cid/ciaa1482.
     PubMed     Abstract available
     
     
     
215. MARTYN EM, Bangdiwala AS, Kagimu E, Rutakingirwa MK, et al
     Cerebrospinal fluid bacillary load by Xpert MTB/RIF Ultra PCR Cycle Threshold value predicts two-week mortality in HIV-associated tuberculous meningitis.
     Clin Infect Dis. 2020 Sep 28. pii: 5912549. doi: 10.1093/cid/ciaa1444.
     PubMed     Abstract available
     
     
     July 2020
216. MIRANDA C, Bark CM
     TB, or not TB, the Choice Is Ours.
     Clin Infect Dis. 2020;71:291-292.
     PubMed    
     
     
     
217. BOLD TD, Cheng MP, Marty FM
     Reply to Singh.
     Clin Infect Dis. 2020;71:471-472.
     PubMed    
     
     
     June 2020
218. JIANG Q, Liu Q, Ji L, Li J, et al
     Citywide Transmission of Multidrug-resistant Tuberculosis Under China's Rapid Urbanization: A Retrospective Population-based Genomic Spatial Epidemiological Study.
     Clin Infect Dis. 2020;71:142-151.
     PubMed     Abstract available
     
     
     
219. DONOVAN J, Cresswell FV, Thuong NTT, Boulware DR, et al
     Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward.
     Clin Infect Dis. 2020 Jun 16. pii: 5858077. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2020
220. HORSBURGH CR
     "Plus Ca Change...".
     Clin Infect Dis. 2020;70:2119-2120.
     PubMed    
     
     
     April 2020
221. HERMANS SM, Zinyakatira N, Caldwell J, Cobelens FGJ, et al
     High rates of recurrent TB disease: a population-level cohort study.
     Clin Infect Dis. 2020 Apr 25. pii: 5825249. doi: 10.1093.
     PubMed     Abstract available
     
     
     
222. ALFFENAAR JC, Gumbo T, Dooley KE, Peloquin CA, et al
     Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis.
     Clin Infect Dis. 2020;70:1774-1780.
     PubMed     Abstract available
     
     
     March 2020
223. CHENG MP, Marty FM
     Reply to Aronson et al.
     Clin Infect Dis. 2020;70:1262.
     PubMed    
     
     
     February 2020
224. VAN DER WERF MJ, Rosales-Klintz S, de Vlas SJ
     Screening for Latent Tuberculosis (TB) Infection in Low TB Incidence Countries.
     Clin Infect Dis. 2020;70:716-717.
     PubMed    
     
     
     
225. MIYAHARA S, Ramchandani R, Kim S, Evans SR, et al
     Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.
     Clin Infect Dis. 2020;70:698-703.
     PubMed     Abstract available
     
     
     January 2020
226. UGARTE-GIL C, Pearson F, Moore D, Critchley J, et al
     Reply to Yates and Barr.
     Clin Infect Dis. 2020;70:545-546.
     PubMed    
     
     
     
227. HONG H, Dowdy DW
     Reply to Chen, Song, and Liu.
     Clin Infect Dis. 2020;70:547-548.
     PubMed    
     
     
     
228. CHEN HL, Song YP, Liu K
     Prediction Model Needs More Improvements Before Clinical Application.
     Clin Infect Dis. 2020;70:546-547.
     PubMed    
     
     
     November 2019
229. MANABE YC, Andrade BB, Gupte N, Leong S, et al
     A Parsimonious Host Inflammatory Biomarker Signature Predicts Incident TB and Mortality in Advanced HIV.
     Clin Infect Dis. 2019 Nov 25. pii: 5639757. doi: 10.1093/cid/ciz1147.
     PubMed     Abstract available
     
     
     September 2019
230. MNGQIBISA R, Kendall MA, Dooley K, Wu X, et al
     Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate (DMPA) in African women receiving treatment for HIV and TB: Potential concern for standard dosing frequency.
     Clin Infect Dis. 2019 Sep 5. pii: 5561543. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2019
231. RAVIMOHAN S, Auld SC, Maenetje P, Ratsela N, et al
     Lung injury on antiretroviral therapy in adults with HIV/TB.
     Clin Infect Dis. 2019 Jun 26. pii: 5523721. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2019
232. THAO LTP, Wolbers M, Heemskerk AD, Thi Hoang Mai N, et al
     Dynamic prediction of death in patients with tuberculous meningitis using time-updated Glasgow coma score and plasma sodium measurements.
     Clin Infect Dis. 2019 Apr 4. pii: 5427068. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.